Last reviewed · How we verify
Peptostreptococcus Pelvic Inflammatory Disease
Approved treatments
- Pipracil
Pipracil works by inhibiting bacterial cell wall synthesis, ultimately leading to cell lysis and death. - Mefoxin In Sodium Chloride 0.9% In Plastic Container
- Cefotan
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Peptostreptococcus Pelvic Inflammatory Disease patent landscape — cliff calendar, originator estates, attackable patents
- Peptostreptococcus Pelvic Inflammatory Disease treatment landscape brief
- Peptostreptococcus Pelvic Inflammatory Disease treatment updates RSS
Frequently asked questions about Peptostreptococcus Pelvic Inflammatory Disease
What drugs treat Peptostreptococcus Pelvic Inflammatory Disease?
Tracked treatments include Pipracil, Mefoxin In Sodium Chloride 0.9% In Plastic Container, Cefotan.
What is the treatment for Peptostreptococcus Pelvic Inflammatory Disease?
Standard treatment for Peptostreptococcus Pelvic Inflammatory Disease includes Pipracil, Mefoxin In Sodium Chloride 0.9% In Plastic Container, Cefotan. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Peptostreptococcus Pelvic Inflammatory Disease patent cliff · Peptostreptococcus Pelvic Inflammatory Disease CI report
- Treatment: Pipracil
- Treatment: Mefoxin In Sodium Chloride 0.9% In Plastic Container
- Treatment: Cefotan
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing